Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony‐stimulating factor derivative Maxy‐G34 and pegfilgrastim in rats

Autor: Scholz, M., Engel, C., Apt, D., Sankar, S. L., Goldstein, E., Loeffler, M.

Objectives: This study aims to compare pharmacokinetics and pharmacodynamics of pegfilgrastim, a pharmaceutical recombinant human granulocyte colony‐stimulating factor (rhG‐CSF), with that of a newly developed reagent, Maxy‐G34. This comparison

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5aec9ed57a584bea6201b917fe2ed024
https://europepmc.org/articles/PMC6496908/

Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.

Autor: Scholz M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107 Leipzig, Germany. markus.scholz@imise.uni-leipzig.de, Engel C, Apt D, Sankar SL, Goldstein E, Loeffler M

Publikováno v: Cell proliferation [Cell Prolif] 2009 Dec; Vol. 42 (6), pp. 823-37. Date of Electronic Publication: 2009 Sep 24.